Our mission is to provide our customers and our partners with the best quality membrane targets/antigens for their discovery projects in order to develop more reliable and better performing drug and vaccine candidates for better health accessible to all.

Isolate and stabilize native membrane protein targets starting from any biological material


Our innovative technologies and approaches allow the deorphanization, identification of new targets / antigens and their isolation in the highest quality conditions for conformational antibody development, vaccine development, high throughput ligands screening, structure-based drug discovery, assays and immunoassays.

Our know-how  and technological platform are relevant to downstream processing (DSP) as well as upstream processing (USP – expression part) applications and detergent quantification.

To learn more about our process see Technology Platform or Case Studies.